FDA panel ap­proves of blind­ness ther­apy

Richmond Times-Dispatch - - NATION & WORLD -

SIL­VER SPRING, Md. —

A po­ten­tially ground­break­ing treat­ment for a rare form of blind­ness moved one step closer to U.S. ap­proval Thurs­day, as fed­eral health ad­vis­ers en­dorsed the ex­per­i­men­tal gene ther­apy for pa­tients with an in­her­ited con­di­tion that grad­u­ally de­stroys eye­sight.

The vote amounts to a rec­om­men­da­tion to ap­prove the ther­apy. The FDA has un­til mid-Jan­uary to make its de­ci­sion and does not have to fol­low the panel’s rec­om­men­da­tion, though it of­ten does.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.